Bayer’s not breaking up. At least not yet
Will Bayer respond to long-time pressures to separate its drug and agricultural business? On the question of breaking up the company, “our answer is ‘not now,’” CEO Bill Anderson said, “and…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning, everyone. Damian here with news of another biotech megaround, the potential next big thing from Novo Nordisk, and an anti-aging dispute involving dogs.
What's Your Reaction?
